Access Resources
5961 - 5970 of 7616 Results
Title
Year
-
RESTRICTEDTitle: Ser(P)‐1292 LRRK2 in urinary exosomes is elevated in idiopathic Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 10Start Page: 1543End Page: 1550Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26686Best OA location URL: https://europepmc.org/articles/pmc5053851?pdf=renderCitation Count: 145
-
RESTRICTEDTitle: The best medicine? The influence of physical activity and inactivity on Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 10Start Page: 1444End Page: 1454Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26728Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491025Citation Count: 93
- Integrative transcriptomic meta-analysis of Parkinson’s disease and depression identifies NAMPT as a potential blood biomarker for de novo Parkinson’s disease2016RESTRICTEDTitle: Integrative transcriptomic meta-analysis of Parkinson’s disease and depression identifies NAMPT as a potential blood biomarker for de novo Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/srep34579Best OA location URL: https://www.nature.com/articles/srep34579.pdfCitation Count: 32
- Reproducibility of locus coeruleus and substantia nigra imaging with neuromelanin sensitive MRI2016RESTRICTEDTitle: Reproducibility of locus coeruleus and substantia nigra imaging with neuromelanin sensitive MRIJournal Name: Magnetic Resonance Materials in Physics, Biology and MedicinePublisher: Springer Science and Business Media LLCVol: 30Issue #: 2Start Page: 121End Page: 125Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10334-016-0590-zCitation Count: 69
-
RESTRICTEDTitle: Ade novocompound targeting α-synuclein improves deficits in models of Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 139Issue #: 12Start Page: 3217End Page: 3236Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/brain/aww238Best OA location URL: https://academic.oup.com/brain/article-pdf/139/12/3217/24173157/aww238.pdfCitation Count: 116
-
RESTRICTEDTitle: Immunomodulators as Therapeutic Agents in Mitigating the Progression of Parkinson’s DiseaseJournal Name: Brain SciencesPublisher: MDPI AGVol: 6Issue #: 4Start Page: 41End Page: 41Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci6040041Best OA location URL: https://www.mdpi.com/2076-3425/6/4/41/pdf?version=1474633139Citation Count: 18
-
RESTRICTEDTitle: Self-Reported Symptoms of Parkinson’s Disease by Sex and Disease DurationJournal Name: Western Journal of Nursing ResearchPublisher: SAGE PublicationsVol: 39Issue #: 11Start Page: 1412End Page: 1428Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/0193945916670904Best OA location URL: https://europepmc.org/articles/pmc5505809?pdf=renderCitation Count: 11
- Loss of Pink1 modulates synaptic mitochondrial bioenergetics in the rat striatum prior to motor symptoms: concomitant complex I respiratory defects and increased complex II‐mediated respiration2016RESTRICTEDTitle: Loss of Pink1 modulates synaptic mitochondrial bioenergetics in the rat striatum prior to motor symptoms: concomitant complex I respiratory defects and increased complex II‐mediated respirationJournal Name: PROTEOMICS – Clinical ApplicationsPublisher: WileyVol: 10Issue #: 12Start Page: 1205End Page: 1217Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/prca.201600005Best OA location URL: https://europepmc.org/articles/pmc5810131?pdf=renderCitation Count: 27
- Lack of Antiparkinsonian Effects of Systemic Injections of the Specific T-Type Calcium Channel Blocker ML218 in MPTP-Treated Monkeys2016RESTRICTEDTitle: Lack of Antiparkinsonian Effects of Systemic Injections of the Specific T-Type Calcium Channel Blocker ML218 in MPTP-Treated MonkeysJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 7Issue #: 11Start Page: 1543End Page: 1551Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00186Best OA location URL: https://europepmc.org/articles/pmc5510653?pdf=renderCitation Count: 9
- Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism2016RESTRICTEDTitle: Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropismJournal Name: Gene TherapyPublisher: Springer Science and Business Media LLCVol: 23Issue #: 11Start Page: 807End Page: 814Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/gt.2016.62Best OA location URL: https://www.nature.com/articles/gt201662.pdfCitation Count: 56